Short description
RayzeBio is a pharmaceuticals company that develops targeted radiopharmaceutical drugs for cancer.
Description
RayzeBio is focused on improving outcomes for people with cancer by harnessing the power of targeted radioisotopes. As the emerging leader in radiopharmaceuticals, RayzeBio is developing an innovative robust pipeline against validated oncology drug targets to deliver radioisotopes that emit alpha particles such as Actinium-225.
Last funding
Absolutely Noaccess
Sign in for full access
Total funding
$$2020202
Sign in for full access
Location
San Diego, California, United States, North America
Founded on
January 1, 2018
Exited on
September 15, 2023
Went public on
September 15, 2023
Stock symbol
RYZB
Non-profit?
No
Acquired?
No
Employees count
51-100
Investors
Cannot Access, Uh Ohhhh, Uh Ohhhh, Noaccess, Noaccessforu, Noaccess, Uh Ohhhh, Nopepepe, Absolutely Noaccess, Absolutely Noaccess, Noaccessforu, Noaccess, Noaccessforu, Noaccess, Blurry Noaccess, No Way, Uh Ohhhh, Noaccess, Absolutely Noaccess, Noaccess, Nopepepe, Cannot Access
Sign in for full access
Founders
Aron Knickerbocker, Deborah Charych